for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Fujifilm starts new late-phase trial of Avigan in Japan for COVID-19 patients

TOKYO, April 21 (Reuters) - Fujifilm Holdings Corp said on Wednesday it started a new phase III trial of its anti-influenza drug Avigan in Japan for COVID-19 patients.

The new trial in Japan is targeting patients with early-onset of COVID-19 who have risk factors for progression to severe symptoms, Fujifilm said in a release.

Domestic approval of the drug for COVID-19 was delayed after a health ministry panel said in December that trial data was inconclusive. (Reporting by Rocky Swift; Editing by Jacqueline Wong)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up